Search Results - "Komajda, M."

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study by Swedberg, Karl, Prof, Komajda, Michel, Prof, Böhm, Michael, Prof, Borer, Jeffrey S, Prof, Ford, Ian, Prof, Dubost-Brama, Ariane, MD, Lerebours, Guy, MD, Tavazzi, Luigi, Prof

“…Summary Background Chronic heart failure is associated with high mortality and morbidity. Raised resting heart rate is a risk factor for adverse outcomes. We…”
Get full text

Effect of Nesiritide in Patients with Acute Decompensated Heart Failure by O'Connor, C.M, Starling, R.C, Hernandez, A.F, Armstrong, P.W, Dickstein, K, Hasselblad, V, Heizer, G.M, Komajda, M, Massie, B.M, McMurray, J.J.V, Nieminen, M.S, Reist, C.J, Rouleau, J.L, Swedberg, K, Adams, K.F, Anker, S.D, Atar, D, Battler, A, Botero, R, Bohidar, N.R, Butler, J, Clausell, N, Corbalán, R, Costanzo, M.R, Dahlstrom, U, Deckelbaum, L.I, Diaz, R, Dunlap, M.E, Ezekowitz, J.A, Feldman, D, Felker, G.M, Fonarow, G.C, Gennevois, D, Gottlieb, S.S, Hill, J.A, Hollander, J.E, Howlett, J.G, Hudson, M.P, Kociol, R.D, Krum, H, Laucevicius, A, Levy, W.C, Méndez, G.F, Metra, M, Mittal, S, Oh, B.-H, Pereira, N.L, Ponikowski, P, Tang, W.H.W, Tanomsup, S, Teerlink, J.R, Triposkiadis, F, Troughton, R.W, Voors, A.A, Whellan, D.J, Zannad, F, Califf, R.M

“…Nesiritide was approved by the FDA on the basis of small clinical trials for the treatment of acute heart failure. In this large clinical trial, nesiritide did…”
Get full text

The current and future management of acute heart failure syndromes by Pang, Peter S., Komajda, Michel, Gheorghiade, Mihai

“…Hospitalization for heart failure (HF) marks a substantial crossroad for patients, as greater than one-third will be re-hospitalized or dead within 90 days…”
Get full text

Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II by Komajda, Michel, Hanon, Olivier, Hochadel, Matthias, Lopez-Sendon, Jose Luis, Follath, Ferenc, Ponikowski, Piotr, Harjola, Veli-Pekka, Drexler, Helmut, Dickstein, Kenneth, Tavazzi, Luigi, Nieminen, Markku

“…Aims International guidelines are frequently not implemented in the elderly population with heart failure (HF). This study determined the management of…”
Get full text

Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: An efficacy and safety analysis of SHIFT study by Tavazzi, L, Swedberg, K, Komajda, M, Böhm, M, Borer, J.S, Lainscak, M, Robertson, M, Ford, I

“…Abstract Background Heart failure (HF) and chronic obstructive pulmonary disease (COPD) frequently coexist, with undefined prognostic and therapeutic…”
Get full text

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial by Poole-Wilson, Philip A, Swedberg, Karl, Cleland, John GF, Di Lenarda, Andrea, Hanrath, Peter, Komajda, Michel, Lubsen, Jacobus, Lutiger, Beatrix, Metra, Marco, Remme, Willem J, Torp-Pedersen, Christian, Scherhag, Armin, Skene, Allan

“…β blockers reduce mortality in patients who have chronic heart failure, systolic dysfunction, and are on background treatment with diuretics and…”
Get full text

The EuroHeart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis by CLELAND, J. G. F, SWEDBERG, K, MADEIRA, H. C, MOISEYEV, V. S, PREDA, I, VAN GILST, W. H, WIDIMSKY, J, FREEMANTLE, N, EASTAUGH, Joanne, MASON, J, FOLLATH, F, KOMAJDA, M, COHEN-SOLAL, A, AGUILAR, J. C, DIETZ, R, GAVAZZI, A, HOBBS, R, KOREWICKI, J

“…The European Society of Cardiology (ESC) has published guidelines for the investigation of patients with suspected heart failure and, if the diagnosis is…”
Get full text

The Euroheart Failure Survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment by Komajda, M, Follath, F, Swedberg, K, Cleland, J, Aguilar, J C, Cohen-Solal, A, Dietz, R, Gavazzi, A, Van Gilst, W H, Hobbs, R, Korewicki, J, Madeira, H C, Moiseyev, V S, Preda, I, Widimsky, J, Freemantle, N, Eastaugh, J, Mason, J

“…National surveys suggest that treatment of heart failure in daily practice differs from guidelines and is characterized by underuse of recommended medications…”
Get full text

Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey by Shoaib, Ahmad, Farag, M., Nolan, J., Rigby, A., Patwala, A., Rashid, M., Kwok, C. S., Perveen, R., Clark, A. L., Komajda, M., Cleland, J. G. F.

“…Background Heart failure is heterogeneous in aetiology, pathophysiology, and presentation. Despite this diversity, clinical trials of patients hospitalized for…”
Get full text

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey by Lenzen, M.J, Scholte op Reimer, W.J.M, Boersma, E, Vantrimpont, P.J.M.J, Follath, F, Swedberg, K, Cleland, J, Komajda, M

“…Aims Due to a lack of clinical trials, scientific evidence regarding the management of patients with chronic heart failure and preserved left ventricular…”
Get full text

Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey by de Groote, P., Isnard, R., Assyag, P., Clerson, P., Ducardonnet, A., Galinier, M., Jondeau, G., Leurs, I., Thébaut, J.-F., Komajda, M.

“…Background Recent registries have shown that recommended drugs for the treatment of chronic heart failure (CHF) are under-prescribed in daily practice. Aims To…”
Get full text

Accelerating progress on non-communicable diseases by Sacco, RL, Smith, SC, Holmes, D, Shurin, S, Brawley, O, Cazap, E, Glass, R, Komajda, M, Koroshetz, W, Mayer-Davis, E, Mbanya, JC, Sledge, G, Varmus, H

“…[...]comprehensive smoke-free air laws in public buildings have been estimated to result in a saving of $10 billion annually in health-care costs by…”
Get full text

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD) : study design and protocol by HOME, P. D, POCOCK, S. J, BECK-NIELSEN, H, GOMIS, R, HANEFELD, M, DARGIE, H, KOMAJDA, M, GUBB, J, BISWAS, N, JONES, N. P

“…Studies suggest that in addition to blood glucose concentrations, thiazolidinediones such as rosiglitazone improve some cardiovascular (CV) risk factors and…”
Get full text

Rosiglitazone RECORD study: glucose control outcomes at 18 months by Home, P. D., Jones, N. P., Pocock, S. J., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Komajda, M., Curtis, P.

“…Aims  To compare glucose control over 18 months between rosiglitazone oral combination therapy and combination metformin and sulphonylurea in people with…”
Get full text

New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey by Rivero-Ayerza, Maximo, Scholte op Reimer, Wilma, Lenzen, Mattie, Theuns, Dominic A.M.J., Jordaens, Luc, Komajda, Michel, Follath, Ferenc, Swedberg, Karl, Cleland, John G.F.

“…Aims The prognostic significance of atrial fibrillation (AF) in hospitalized patients with heart failure (HF) remains poorly understood. To evaluate in what…”
Get full text

Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis by Berry, C, Poppe, K K, Gamble, G D, Earle, N J, Ezekowitz, J A, Squire, I B, McMurray, J J V, McAlister, F A, Komajda, M, Swedberg, K, Maggioni, A P, Ahmed, A, Whalley, G A, Doughty, R N, Tarantini, L

“…Anaemia is common among patients with heart failure (HF) and is an important prognostic marker. We sought to determine the prognostic importance of anaemia in…”
Get full text

Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I by Komajda, Michel, Hanon, Olivier, Hochadel, Matthias, Follath, Ferenc, Swedberg, Karl, Gitt, Anselm, Cleland, John G.F.

“…Aims Here, the aim is to study the management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I. Heart Failure (HF) is common in…”
Get full text

Physicians’ Adherence to Guideline Recommended Drug Therapy in Systolic Heart Failure: Australian Data From the International Qualify Survey by Macdonald, P, Krum, H, Djidel, P, Komajda, M

Get full text

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial by Metra, Marco, Torp-Pedersen, Christian, Swedberg, Karl, Cleland, John G.F., Di Lenarda, Andrea, Komajda, Michel, Remme, Willem J., Lutiger, Beatrix, Scherhag, Armin, Lukas, Mary Ann, Charlesworth, Andrew, Poole-Wilson, Philip A.

“…Aims We studied the influence of heart rate (HR), systolic blood pressure (SBP), and beta-blocker dose on outcome in the 2599 out of 3029 patients in…”
Get full text

Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology by Fraser, Alan G, Daubert, Jean-Claude, Van de Werf, Frans, Estes, 3rd, N A Mark, Smith, Jr, Sidney C, Krucoff, Mitchell W, Vardas, Panos E, Komajda, Michel

“…The European Commission announced in 2008 that a fundamental revision of the medical device directives is being considered in order to clarify and strengthen…”
Get full text